This bill amends the definition and regulations surrounding medical cannabidiol in Iowa, specifically expanding the definition to include inhalable forms of flowers from the Cannabis sativa L. or Cannabis indica plants. It mandates the medical cannabidiol board to establish packaging requirements for these vaporizable products and prohibits dispensaries from selling inhalable forms to individuals under 21 years of age. Additionally, the bill introduces new requirements for medical cannabidiol registration cards, which must now include a statement indicating that patients and primary caregivers cannot possess more tetrahydrocannabinol than they are authorized to purchase within a 90-day period.

Furthermore, the bill modifies the affirmative defenses available in cases of unlawful possession of marijuana, stipulating that these defenses only apply if the patient or primary caregiver possesses an amount of tetrahydrocannabinol that does not exceed their authorized purchase limit. It also clarifies that the provisions of this chapter do not restrict individuals from manufacturing, selling, or possessing hemp products as permitted by existing laws. Overall, the bill aims to enhance the regulatory framework for medical cannabidiol while ensuring patient safety and compliance with established limits.

Statutes affected:
Introduced: 124E.2, 124E.4, 124E.9, 124E.12